This cross-sectional study was designed to investigate the extent of genetic susceptibility by targeting variants in interleukin (IL)24/IL-13 signalling pathways leading to atopic disease in early childhood. We evaluated involvement of five single nucleotide polymorphisms IL4 C-590T, IL13 C-1055T, IL13 Arg130Gln, IL4RA Ile50Val and IL4RA Gln576Arg, in the control of serum total and antigen-specific immunoglobulin (Ig)E levels. Furthermore, we analysed their association with changes in gene expression of five cytokines having key roles in inflammatory and anti-inflammatory immune response [IL-4, IL-13, interferon (IFN)-g, IL-8 and IL-10]. Total and antigen-specific IgE levels in serum and gene expression of selected cytokines in peripheral blood were measured in 386 children aged 1-8 years. TaqMan allelic discrimination, amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and restriction fragment length polymorphisms (RFLP) methods validated by sequencing were used for genotyping. All genotypes for children with total and antigen-specific IgE levels in the normal range were in Hardy-Weinberg equilibrium. Gene expression analyses were carried out using TaqMan gene expression assays. We found elevated total IgE levels in carriers of IL13 Arg130Gln variant allele [odds ratio (OR) 5 1Á84; 95% confidence interval (CI) 5 1Á16-2Á93]. This effect was more apparent for boys (OR 5 2Á31; 95% CI 5 1Á25-4Á28). However, no significant association was observed for the other four variants examined. We found up-regulation of IFN-g in children with elevated serum total IgE levels carrying the Arg130 allele (P 5 0Á005). No differences were found for IL4, IL8 or IL10, while IL13 gene expression was under the detection limit. IL13 Arg130Gln genotypes can play a role in genetic susceptibility to allergy via regulation of serum total IgE levels and affecting IFN-g gene expression.
Introduction
Allergic diseases resulting from T helper type 2 (Th2)-mediated inflammation represent a significant global health problem due to their continual rise in developed countries. Therefore, there is a great interest in detecting biomarkers of susceptibility that can be used to identify risk and prevent adverse health effects through prevention and intervention strategies.
Atopy is an exaggerated immunoglobulin (Ig)E-mediated immune response resulting in the development of certain allergic diseases. Among them, the most typical for childhood are atopic dermatitis, allergic rhinitis and asthma. As well as environmental factors, genetic variability is associated with increased susceptibility to this condition. Chromosome 5q.31-33 contains several candidate loci, including genes for Th2 cytokines interleukin (IL)24 and IL-13, that are the central mediators of allergic inflammation [1] . They exert their biological effects by binding to their functional receptors on target cells having the IL-4 receptor alpha chain (IL-4Ra) as a component [2] .
Cytokines play a crucial role in atopic diseases by alteration of the balance between the Th1 and Th2 immune responses triggered by lifestyle factors and environmental exposure. Cytokine profiles measured in peripheral blood may not only reflect cellular functions, but can also indicate cellular composition in the immune system. The expression of inflammatory and anti-inflammatory cytokines IL-4, IL-13, IL-10, IL-8 and interferon (IFN)-g, measured in peripheral blood in our study, is mediated by different cell types. Whereas IL-4 and IL-13 are expressed mainly by Th2 cells [3] , IL-10 is produced by various immune cell types including Th1, Th2 and Th17 cell subsets, regulatory T cells, CD8
1 T cells and B cells [4] . The IL-8 chemokine, one of the main mediators of inflammatory response, is produced in macrophages, epithelial cells, endothelial cells and human peripheral blood eosinophils [5] . IFN-g is secreted predominantly by natural killer and natural killer T cells, as well as by CD4 Th1 and CD8 cytotoxic T cells once antigen-specific immunity develops [6] . The impact of genetic variation in IL4 and IL13 genes on expression of inflammatory and anti-inflammatory cytokines in atopic diseases has not been studied widely [7] .
We selected five functional variants in three genes, namely IL4 variant C-590T (rs2243250), IL13 variants C-1055T (rs1800925) and Arg130Gln (rs20541) and two IL4RA variants Ile50Val (rs1805010) and Gln576Arg (rs1801275) to analyse their impact on serum total and antigen-specific IgE levels and their influence on gene expression of selected inflammatory/anti-inflammatory cytokines IL-4, IL-13, IL-8, IL-10 and IFN-g. Changes in their expression profiles can play a significant role in the Th1/Th2 immune balance and inflammatory response. To ascertain genetic effects on IgE levels that are representative of the general population, we conducted a cross-sectional study with the aim of evaluating the extent of genetic susceptibility by targeting candidate single nucleotide polymorphisms (SNPs) in pathways leading to atopic disease in early childhood.
Methods

Subjects
This study involved 418 children from two Slovak regionsBratislava and Star a L'ubov na. Of these, 386 children aged 1-8 years provided biological samples for moleculargenetic analyses between 2002 and 2009. Characteristics of the study subjects are summarized in Table 1 . Children were recruited in co-operation with regional paediatricians. Inclusion criteria for enrolment into the study were atopic dermatitis, respiratory allergy, chronic urticaria or gastrointestinal problems with suspect food allergy. Exclusion criteria were acute infectious disease, systemic corticosteroid therapy, tuberculosis (TB), HIV and any malignancies. Children were examined clinically and samples of peripheral blood for genotyping and IgE measurements were taken using standardized protocols. The questionaires focused on lifestyle, family habits and nutritional factors and were administered to parents.
After centrifugation, serum was collected and frozen for analyses of total and antigen-specific IgE. Peripheral blood for genotyping was drawn into ethylenediamine tetraacetic acid (EDTA) anti-coagulant tubes and frozen at 2208C. Questionnaires focused on environmental risk factors for allergy development were administered to mothers. None of the children received inhaled or topical corticosteroids. To reduce potential histamine-mediated effects in children receiving anti-histamines, a 10-day washout period preceded blood sampling.
All studies were approved by the Ethics Committee of the Slovak Medical University and parents of participants gave written informed consent. Samples were coded and analyses were performed in a blinded fashion.
Total and specific serum IgE measurement
Total serum IgE levels were measured using enzyme-linked immunosorbent assay (ELISA). The age-specific reference intervals based on data from the available literature were defined as follows: < 20 kU/l for age 0-3 years, < 35 kU/l for 3-4 years, < 60 kU/l for 4-7 years and < 110 kU/l for 7-14 years [8, 9] . Peak IgE levels greater than the agespecific normal ranges listed above were referred to as 'elevated' IgE.
Specific IgE antibodies were determined by means of ImmunoCap-radioallergosorbent test-fluorescence enzyme immunoassay (CAP-RAST-FEIA) (Pharmacia, Uppsala, Sweden) and EUROLINE (EUROIMMUN AG, L€ ubeck, Germany) test systems. In the case of CAP-RAST- FEIA, we defined sensitization to the most common specific food (milk, egg white, fish, wheat, soy, nuts) and inhalation allergens (dog dander, cat dander, grass and tree pollen weeds and house dust mite) as a concentration of !0Á35 kU/l of the antigen-specific IgE. The results of the test for specific allergens (test for 16 allergens) of the EUROLINE test system were interpreted as 0 -no signs of allergen-specific IgE, 1 low concentration of allergenspecific IgE, 11 moderate elevation of specific IgE and 111 high concentration of allergen-specific IgE. Allergens tested were: egg white, egg yolk, milk, yeast, wheat flour, rye flour, rice, soya, peanut, hazelnut, almond, apple, kiwi, apricot, tomato, carrot, potato, celery, codfish and crab.
DNA extraction and genotyping
DNA for genotyping was extracted from peripheral blood of 386 children using a modified salting-out method [10] .
Five putatively functional SNPs located in IL13, IL4 and IL4RA genes were genotyped by restriction fragment length polymorphisms-polymerase chain reaction (RFLP-PCR), TaqMan allelic discrimination and allele-specific PCR [amplification refractory mutation system (ARMS)-PCR] [11] [12] [13] [14] [15] [16] . Genotyping method, primer sequences and PCR conditions for individual SNPs are shown in Table 2 . Genotyping results were validated by direct sequencing at the Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava. In the case of agreement of both methods we performed further evaluation. All observed genotype frequencies in children with both total and antigen-specific IgE levels in the normal range were within Hardy-Weinberg equilibrium (HWE).
RNA isolation and reverse transcription
The PAXgene Blood RNA Isolation System (PreAnalytiX GmbH, Hombrechtikon Switzerland) was used for isolation of total RNA from the peripheral blood of 207 children. The whole blood was collected into PAXgene Blood RNA tubes and stored at 2208C. Total RNA was isolated from blood samples using the PAXgene Blood RNA Kit (Qiagen, Valencia, CA, USA), including 15-min DNase treatment at room temperature. RNA concentration and quality were determined by gel electrophoresis and spectrophotometrically at 260/280 nm.
Total RNA was converted into cDNA using TaqMan reverse transcription reagents (Applied Biosystems, Carlsbad, CA, USA) with MultiScribe reverse transcriptase and random hexamers. cDNA was prepared from 2 lg of mRNA. The samples were incubated at 258C for 10 min and 428C for 61 min; the reaction was stopped by heating at 958C for 5 min. The resulting cDNA was diluted into 5 ng/ll aliquots and stored at 2208C. 
Real-time PCR
Real-time PCR reactions were performed using the ABI Prism 7500 sequence detection system (Applied Biosystems) and TaqMan gene expression assays (Applied Biosystems): Hs00174086_m1 (IL10); Hs00174103_m1 (IL8); Hs00174143_m1 (IFNG); Hs00174122_ml (IL4); Hs00174379_m1 (IL13) and Hs99999905_m1 (GAPDH) as internal control. A single-plex reaction mix was prepared according to the manufacturer's instructions. Aliquots of cDNA were amplified in the 20 ll reaction mixture for IL8, IL10 and IFNG and in a 50 ll reaction mixture for IL4. All amplifications were carried out in triplicate. The thermal cycling conditions included an initial activation of DNA polymerase 10 min at 958C, followed by 40 cycles (958C for 15 s and 608C for 1 min).
Quantification cycle (Cq) values were determined by automated threshold analysis using ABI Prism Sequence Detection Software version 1.3.1 (Applied Biosystems) and relative gene expression was calculated using the 2 -DDCt method. The results were reported as the n-fold change in cytokine gene expression in the experimental group normalized to the endogenous control glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and relative to the control group (5 1). Data represent mean 6 standard error of the mean (s.e.m.) of three independent experiments.
Statistical analysis
Normality of distribution was tested by Kolmogorov-Smirnoff test. If distributed normally, sample means were tested by Student's t-test or analysis of variance (ANOVA) with Bonferroni's or Tamhane's tests for multiple comparisons depending on homogeneity of variance. The non-parametric Mann-Whitney U-test was used for non-normally distributed data. All tests were two-tailed, performed at the significance level a 5 0Á05. A likelihood ratio test was applied to assess whether the observed genotypes were in HWE. Categorical data were tested by v 2 test. Multivariate logistic regression was used to test the association between elevated total IgE levels (categorized by age of children) and analysed genetic variants after adjusting for sex as a confounder. All relative quantifications were calculated using REST software, RG mode, using pairwise fixed randomization test [17] . The significance of fold change in gene expression between groups was analysed using Student's t-test (data were 
Results
Clinical characteristics of the studied population are shown in Table 1 . We found elevated serum total IgE levels in 32Á1% children, while elevated antigen-specific IgE levels were present in 32Á4%. Elevated total IgE levels were more frequent in boys (40Á6 versus 23Á3%; P < 0Á001), while elevated antigen-specific IgE levels occurred more often in girls (35Á4 versus 29Á4%). Among 386 children 220 (57Á0%), 107 boys (54Á3%) and 113 girls (59Á8%) had both total and antigen-specific IgE levels in the normal range. Frequencies of IL4, IL13 and IL4RA polymorphisms in the studied population are shown in Table 3 . They were similar to those published in 1000 Genomes Phase 3 for the CEU (Utah residents with Northern and Western European ancestry) population (http://www.ncbi.nlm.nih.gov/ variation/tools/1000genomes/) (HapMap individuals of European descent). Significant differences between children with normal and elevated serum total IgE levels were found only for the Arg130Gln variant (P 5 0Á024). No association was detected between analysed SNPs and elevated antigenspecific IgE. Among children with elevated total IgE levels, variant allele (Gln130) was found in higher frequency for both homozygotes (10Á9 versus 7Á0%) and heterozygotes (40Á9 versus 29Á5%). This was more apparent in the dominant model, where 51Á8% of children with elevated serum total IgE levels possess the variant allele, in contrast with 36Á5% of those with normal IgE levels (P 5 0Á007). Children carrying the variant allele had elevated serum total IgE levels. This difference reached significance only for boys (P 5 0Á005), who had higher total IgE levels than girls (P 5 0Á008) (Fig. 1) . Multivariate analysis identified the Gln130 allele as an independent risk factor for elevated total IgE, after controlling for sex as a confounder. The results for boys were more significant (P 5 0Á008) if compared to the whole group combined (P 5 0Á010) ( Table 4) . While the presence of the variant allele in the total population studied increased the risk of having elevated total IgE levels 1Á84 times [95% confidence interval (CI) 5 1Á16-2Á93], in boys it was 2Á31 times (95% CI 5 1Á25-4Á28).
Analyses of gene expression of the selected cytokines IL-4, IL-13, IFN-g, IL-10 and IL-8 revealed changed IFN-g expression profile in the carriers of variant IL13 Gln130 allele, compared to wild-type allele (Arg130) carriers. In girls, carriers of the Gln130 allele, the expression of IFN-g was 1Á4 times higher than in Arg130 carriers (P 5 0Á040) (Fig. 2b) . No difference between genotypes was found in boys. Children with normal total IgE concentrations carrying the variant Gln130 allele had a 1Á4 times higher expression of IFN-g compared to those with the Arg130 allele (P 5 0Á033) (Fig. 2c) . Conversely, children with the Arg130 allele and elevated total IgE levels had a 1Á5 times higher IFN-g gene expression than those with normal total IgE levels (P 5 0Á005), but no difference was found in children with the variant allele (Fig. 2e,f) . No differences in the expression of IL-4, IL-10 or IL-8 were found, if stratified by IL13 Arg130Gln genotypes. Gene expression of IL-13 was under the detection limit in peripheral blood of all children.
Discussion
Our results revealing a higher prevalence of elevated total IgE values in boys compared to girls are in agreement with the results published previously for a German paediatric population [9] . The authors showed higher total IgE values in boys than in girls at each age, while sex differences were not significant within the group of atopic children [9] . In our group of children, the prevalence of elevated antigenspecific IgE was more common in girls than in boys. Higher total IgE levels for males were published for different populations and age groups [18, 19] . The influence of IL4, IL13 and IL4RA genetic variants on total IgE levels and atopic diseases have been analysed in different populations, with conflicting results [15, 20, 21] . Among five studied SNPs in our study, only IL13 Arg130Gln variant showed a statistically significant association with total IgE levels. This association could reflect either the direct impact of IL13 Arg130Gln on the IgE phenotype or its tight linkage disequilibrium with a putative susceptibility allele. Total IgE concentrations were reported to be associated with IL13 variants in two large genomewide association studies (GWAS) [22, 23] . Association of the Arg130Gln variant with total IgE levels was also found by other authors [24, 25] . The non-synonymous IL13 Arg130Gln polymorphism results in the non-conservative replacement of arginine130 with glutamine. By comparing the activity of the variant allele Gln130 to that of the common Arg130 variant on primary effector cells of human allergic inflammation, it was shown that Gln130 was significantly more active than the Arg130 allele [26] . According to the authors, increased allergic inflammation in carriers of the Gln130 allele depended on enhanced IL-13-mediated Th2 effector functions rather than increased Th2 differentiation. This gain of function variant affected also IFN-g gene expression in peripheral blood of children. The impact of Gln130 allele was more visible when IgE levels were in the normal range; therefore, we speculate that Gln130 alleleassociated elevated IFN-g gene expression in girls was affected by a lower incidence of elevated total IgE in this group.
Together with Th2, simultaneous Th1 responses have been demonstrated during allergic inflammation accompanied by activation of IFN-g-induced signalling and transcriptional regulation of gene expression by IFN-gregulated genes. IFN-g was shown to play an essential role in reversing allergen-induced airway inflammation and hyperresponsiveness, but it can have dual actions on the latter [27] .
A mixed Th1 and Th2 immune response associated with inflammatory diseases mediated by IL-13 and IFN-g was detected in a mouse model of airway inflammation [28] . Similar findings were published by D'Andrea et al. [29] , who showed that short-term treatment of peripheral blood mononuclear cells with IL-4 or IL-13 enhances their antigen-presenting function and ability to support antigendependent IFN-g production. Their data suggest that IL-4 and IL-13, primary products of the Th2 cells, might play a role in the differentiation and activation of antigenpresenting cells that may favour Th1 cell development. We hypothesize that the Gln130 allele can be more active in enhancing IFN-g production than the wild-type Arg130 allele. As reported previously, the frequencies of both CD4 1 and CD8 1 T cells producing IFN-g, but not type 2 cytokines, increased in subjects with atopic asthma compared with normal subjects [30] . The authors showed that increased production of IFN-g resulted from the skewing of cytokine production towards type 1 as a result of in-vitro stimulation with phorbol myristate acetate (PMA) and ionomycin. To avoid stimulation effects we analysed cytokine mRNA expression in the peripheral blood of children without stimulation. Therefore, low IL-13 expression levels in peripheral blood were not surprising and are in agreement with findings of Cho et al., who investigated the frequencies of IFN-g, IL-4 and IL-5 producing CD4
1 and CD8 1 in blood and sputum T cells from subjects with asthma and normal subjects with and without in-vitro stimulation. They hypothesized that increased cellular activation in allergic asthma leading to increased IFN-g production is a marker of inflammation or is caused by preferential recruitment of allergen-specific Th2/Tc2 cells to the lung, resulting in reduced type 2 cytokine-producing T cells in peripheral blood [30] .
Our results suggest a possible interaction between the Th1 and Th2 immune response that could be mediated by increased IL-13 activity in the Gln130 genetic variant. Coexpression of IL-13, IL-5 and IFN-g has been seen recently in asthmatic children, and was suggested to be a result of interchromosomal interaction, but this interpretation needs to be investigated further [31, 32] .
IL4 and IL4RA polymorphisms were not associated with total IgE levels in our study. Negative findings for these polymorphisms could be explained by their indirect effect on allergic disorders rather than their impact upon total IgE level, or they could be modifier genes affecting disease severity [15] .
To conclude, IL13 Arg130Gln variant can play a role in genetic susceptibility to allergy by participating in serum total IgE level regulation and affecting IFN-g gene expression.
